Discontinuation of tenofovir disoproxil fumarate from initial ART regimens because of renal adverse events: An analysis of data from four multi-country clinical trials

Discontinuation of tenofovir disoproxil fumarate from initial ART regimens because of renal adverse events: An analysis of data from four multi-country clinical trials

Show other versions (1)
Bibliographic Details
Main Authors: McNeil Ngongondo, Justin Ritz, Michael D. Hughes, Mitch Matoga, Mina C. Hosseinipour
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2024-01-01
Series:PLOS Global Public Health
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10766173/?tool=EBI
Description
ISSN:2767-3375

Similar Items